360 related articles for article (PubMed ID: 25961931)
1. Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate.
Scala F; Brighenti E; Govoni M; Imbrogno E; Fornari F; Treré D; Montanaro L; Derenzini M
Oncogene; 2016 Feb; 35(8):977-89. PubMed ID: 25961931
[TBL] [Abstract][Full Text] [Related]
2. Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.
Turi Z; Senkyrikova M; Mistrik M; Bartek J; Moudry P
Cell Cycle; 2018; 17(1):92-101. PubMed ID: 29143558
[TBL] [Abstract][Full Text] [Related]
3. Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why.
Derenzini E; Rossi A; Treré D
J Hematol Oncol; 2018 May; 11(1):75. PubMed ID: 29855342
[TBL] [Abstract][Full Text] [Related]
4. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic drugs inhibit ribosome biogenesis at various levels.
Burger K; Mühl B; Harasim T; Rohrmoser M; Malamoussi A; Orban M; Kellner M; Gruber-Eber A; Kremmer E; Hölzel M; Eick D
J Biol Chem; 2010 Apr; 285(16):12416-25. PubMed ID: 20159984
[TBL] [Abstract][Full Text] [Related]
6. Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines.
Montanaro L; Mazzini G; Barbieri S; Vici M; Nardi-Pantoli A; Govoni M; Donati G; Treré D; Derenzini M
Cell Prolif; 2007 Aug; 40(4):532-49. PubMed ID: 17635520
[TBL] [Abstract][Full Text] [Related]
7. Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility?
Brighenti E; Treré D; Derenzini M
Oncotarget; 2015 Nov; 6(36):38617-27. PubMed ID: 26415219
[TBL] [Abstract][Full Text] [Related]
8. JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner.
Penzo M; Casoli L; Pollutri D; Sicuro L; Ceccarelli C; Santini D; Taffurelli M; Govoni M; Brina D; Trerè D; Montanaro L
Int J Cancer; 2015 Mar; 136(5):E272-81. PubMed ID: 25273595
[TBL] [Abstract][Full Text] [Related]
9. The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells.
Donati G; Bertoni S; Brighenti E; Vici M; Treré D; Volarevic S; Montanaro L; Derenzini M
Oncogene; 2011 Jul; 30(29):3274-88. PubMed ID: 21399665
[TBL] [Abstract][Full Text] [Related]
10. The pre-existing population of 5S rRNA effects p53 stabilization during ribosome biogenesis inhibition.
Onofrillo C; Galbiati A; Montanaro L; Derenzini M
Oncotarget; 2017 Jan; 8(3):4257-4267. PubMed ID: 28032591
[TBL] [Abstract][Full Text] [Related]
11. rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis.
Negi SS; Brown P
Oncotarget; 2015 Jul; 6(20):18094-104. PubMed ID: 26061708
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate.
Brighenti E; Giannone FA; Fornari F; Onofrillo C; Govoni M; Montanaro L; Treré D; Derenzini M
Oncotarget; 2016 Sep; 7(39):63226-63241. PubMed ID: 27557515
[TBL] [Abstract][Full Text] [Related]
13. Ribosome biogenesis dysfunction leads to p53-mediated apoptosis and goblet cell differentiation of mouse intestinal stem/progenitor cells.
Stedman A; Beck-Cormier S; Le Bouteiller M; Raveux A; Vandormael-Pournin S; Coqueran S; Lejour V; Jarzebowski L; Toledo F; Robine S; Cohen-Tannoudji M
Cell Death Differ; 2015 Nov; 22(11):1865-76. PubMed ID: 26068591
[TBL] [Abstract][Full Text] [Related]
14. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition.
Pestov DG; Strezoska Z; Lau LF
Mol Cell Biol; 2001 Jul; 21(13):4246-55. PubMed ID: 11390653
[TBL] [Abstract][Full Text] [Related]
15. MDMX regulation of p53 response to ribosomal stress.
Gilkes DM; Chen L; Chen J
EMBO J; 2006 Nov; 25(23):5614-25. PubMed ID: 17110929
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content.
Morcelle C; Menoyo S; Morón-Duran FD; Tauler A; Kozma SC; Thomas G; Gentilella A
Cancer Res; 2019 Sep; 79(17):4348-4359. PubMed ID: 31292158
[TBL] [Abstract][Full Text] [Related]
17. PIM1 destabilization activates a p53-dependent response to ribosomal stress in cancer cells.
Sagar V; Caldarola S; Aria V; Monteleone V; Fuoco C; Gargioli C; Cannata S; Loreni F
Oncotarget; 2016 Apr; 7(17):23837-49. PubMed ID: 26993775
[TBL] [Abstract][Full Text] [Related]
18. Growth control and ribosomopathies.
Teng T; Thomas G; Mercer CA
Curr Opin Genet Dev; 2013 Feb; 23(1):63-71. PubMed ID: 23490481
[TBL] [Abstract][Full Text] [Related]
19. Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis.
Bursac S; Brdovcak MC; Donati G; Volarevic S
Biochim Biophys Acta; 2014 Jun; 1842(6):817-30. PubMed ID: 24514102
[TBL] [Abstract][Full Text] [Related]
20. AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer.
Chan JC; Hannan KM; Riddell K; Ng PY; Peck A; Lee RS; Hung S; Astle MV; Bywater M; Wall M; Poortinga G; Jastrzebski K; Sheppard KE; Hemmings BA; Hall MN; Johnstone RW; McArthur GA; Hannan RD; Pearson RB
Sci Signal; 2011 Aug; 4(188):ra56. PubMed ID: 21878679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]